Guidance for Implementing a Remote Assessment Strategy as a Protocol Adaptation During the COVID-19 Pandemic Date Published: May 08, 2020 Whitepaper This white paper offers guidance on implementing remote assessment for studies operating during the COVID-19 crisis. Signant Health experts, Dan Debonis and Gary Sachs, discuss methods to collect data that will identify where and how remote ratings are used. They also offer principles to maximize the quantity and quality of data even while operating under conditions of uncertainty. Learn about the important considerations regarding: Legal & regulatory needsOperationsClinical requirementsLogisticsSafetyEngagement Download Now Share: LinkedIn0Tweet0 Recommended Resources Site Perspectives on BYOD ePRO Use Download Whitepaper The 4 S’s of eCOA Success Download Now Whitepaper Digital Health Technologies (DHTs) in Clinical Trials: Key Points from the FDA’S Important Draft Guidance Download Now Whitepaper